EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 143 filers reported holding EPIZYME INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $30,000 | -88.0% | 20,509 | -79.6% | 0.00% | -100.0% |
Q4 2021 | $251,000 | -36.1% | 100,416 | +177.7% | 0.00% | -66.7% |
Q4 2020 | $393,000 | -59.0% | 36,159 | -55.0% | 0.00% | -76.9% |
Q3 2020 | $959,000 | -17.1% | 80,371 | +11.5% | 0.01% | -31.6% |
Q2 2020 | $1,157,000 | +407.5% | 72,057 | +389.9% | 0.02% | +216.7% |
Q1 2020 | $228,000 | -76.3% | 14,709 | -81.1% | 0.01% | -40.0% |
Q1 2019 | $963,000 | +118.9% | 77,700 | +8.7% | 0.01% | +100.0% |
Q4 2018 | $440,000 | +23.2% | 71,453 | +112.0% | 0.01% | +25.0% |
Q3 2018 | $357,000 | +42.2% | 33,700 | +81.7% | 0.00% | +33.3% |
Q2 2018 | $251,000 | +0.8% | 18,549 | +32.0% | 0.00% | -25.0% |
Q1 2018 | $249,000 | -49.5% | 14,052 | -45.7% | 0.00% | -55.6% |
Q3 2017 | $493,000 | +142.9% | 25,902 | +93.0% | 0.01% | +125.0% |
Q2 2017 | $203,000 | +23.0% | 13,423 | +30.3% | 0.00% | -77.8% |
Q4 2015 | $165,000 | – | 10,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |